Factors Influencing the Practice of Health Behavior in Patients with Chronic Obstructive Pulmonary Disease

Abstract

Objectives: Chronic obstructive pulmonary disease is the world's third-largest mortality risk. It is a progressive lung disease characterized by continuous airflow restrictions. Acute exacerbation can be experienced, and respiratory failure and cardiovascular complications occur due to poor. Therefore, this study is to identify factors that affect the practice of health behavior in patients with chronic obstructive pulmonary disease

Methods: The subjects of the study were 64 patients who visited the general hospital's respiratory internal medicine department in K area. Differences in disease knowledge, uncertainty, stress, and health practice levels according to general characteristics were analyzed by independent t-rest and ANOVA. Correlation coefficients were used to determine the relationship between disease knowledge, uncertainty, stress, and health practices. Stepwise multiple regression analysis was conducted to understand the explanatory power of the factors affecting the subject's health practice.

Results: The results of this study are as follows. Firstly, in terms of family history, 53.1% of men had a family history, which was significantly higher than 28.1% of women with a family history.(X2=2.51,  p<.01). Secondly, among the health information on chronic obstructive pulmonary disease, the average of symptom information was 4.83 points, showing the highest score. Thirdly, unpredictability and distress suggest a statistically significant positive correlation(r=0.577, p<.05). Fourthly, the most significant factor was age 5.9%(R2=0.059, p=0.014) which showed an health practice of 24.8% of patients with chronic obstructive pulmonary disease had explanatory power.

Conclusion: Among these variables, medical intervention is needed to increase health information and reduce uncertainty. Therefore, continuous research is needed for the development and application of standardization programs for research tools. The treatment of chronic obstructive pulmonary disease resulted in high costs of 3.52 points on average and control of 3.70 points.